9955ClouDr Group9955 info
$0.15info-2.50%24h
Global rank21923
Market cap$88.13M
Change 7d-6.40%
YTD Performance-82.79%
SP500 benchmarkUnderperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Business data

    ClouDr Group (9955) Stock Overview

    ClouDr Group Limited, an investment holding company, provides supplies and software as a service (SaaS) to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions for chronic condition management. Its in-hospital solution provides chronic condition management solution to hospitals including hospital SaaS and proprietary artificial intelligence of things devices, and value added solutions, such as provision of medical devices and consumables. The company offers pharmacy solution, which includes subscription solution of pharmacy SaaS and the value added solution to provide pharmaceuticals to pharmacies through leveraging data insights generated by SaaS products. In addition, it provides individual chronic condition management solution, which connects doctors and patients primarily acquired through in-hospital solution and pharmacy solution; and provides medical services and health insurance brokerage services. Further, the company offers internet and e-commerce services; and distribution of insurance products. ClouDr Group Limited was founded in 2014 and is headquartered in Hangzhou, China.

    9955 Stock Information

    Symbol
    9955
    Address
    Room 401 Building 4Hangzhou, China
    Founded
    -
    Trading hours
    -
    Website
    https://www.cloudr.cn
    Country
    🇨🇳 China
    Phone Number
    86 40 0921 6690

    ClouDr Group (9955) Price Chart

    -
    Value:-

    ClouDr Group Overview: Key Details and Summary

    Stock data
    2024
    Change
    Price
    $0.15012491162518554
    N/A
    Market Cap
    $88.13M
    N/A
    Shares Outstanding
    587.04M
    N/A
    Employees
    1.49K
    N/A
    logo
    Facebook Icon
    Twitter Icon
    Linkedin Icon
    © 2024 Topstocks.org